BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yajima S, Miyagawa S, Fukushima S, Sakai Y, Iseoka H, Harada A, Isohashi K, Horitsugi G, Mori Y, Shiozaki M, Ohkawara H, Sakaniwa R, Hatazawa J, Yoshioka Y, Sawa Y. Prostacyclin Analogue-Loaded Nanoparticles Attenuate Myocardial Ischemia/Reperfusion Injury in Rats. JACC Basic Transl Sci 2019;4:318-31. [PMID: 31312756 DOI: 10.1016/j.jacbts.2018.12.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zang X, Zhou J, Zhang X, Han Y, Chen X. Ischemia Reperfusion Injury: Opportunities for Nanoparticles. ACS Biomater Sci Eng 2020;6:6528-39. [PMID: 33320610 DOI: 10.1021/acsbiomaterials.0c01197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Miyagawa S, Mizoguchi H, Fukushima S, Imanishi Y, Watabe T, Harada A, Sakai Y, Sawa Y. New regional drug delivery system by direct epicardial placement of slow-release prostacyclin agonist promise therapeutic angiogenesis in a porcine chronic myocardial infarction. J Artif Organs 2021. [PMID: 33761039 DOI: 10.1007/s10047-021-01259-3] [Reference Citation Analysis]
3 Zhao T, Wu W, Sui L, Huang Q, Nan Y, Liu J, Ai K. Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries. Bioact Mater 2022;7:47-72. [PMID: 34466716 DOI: 10.1016/j.bioactmat.2021.06.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kanaya T, Miyagawa S, Kawamura T, Sakai Y, Masada K, Nawa N, Ishida H, Narita J, Toda K, Kuratani T, Sawa Y. Innovative therapeutic strategy using prostaglandin I2 agonist (ONO1301) combined with nano drug delivery system for pulmonary arterial hypertension. Sci Rep 2021;11:7292. [PMID: 33790393 DOI: 10.1038/s41598-021-86781-3] [Reference Citation Analysis]
5 Singh AP, Biswas A, Shukla A, Maiti P. Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal Transduct Target Ther 2019;4:33. [PMID: 31637012 DOI: 10.1038/s41392-019-0068-3] [Cited by in Crossref: 114] [Cited by in F6Publishing: 82] [Article Influence: 57.0] [Reference Citation Analysis]
6 Kim EM, Jeong HJ. Liposomes: Biomedical Applications. Chonnam Med J 2021;57:27-35. [PMID: 33537216 DOI: 10.4068/cmj.2021.57.1.27] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Masada K, Miyagawa S, Sakai Y, Harada A, Kanaya T, Sawa Y. Synthetic Prostacyclin Agonist Attenuates Pressure-Overloaded Cardiac Fibrosis by Inhibiting FMT. Mol Ther Methods Clin Dev 2020;19:210-9. [PMID: 33102614 DOI: 10.1016/j.omtm.2020.09.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]